Luke Beshar

Luke Beshar, MBA

Chairman

Luke Beshar has served on Protara’s board of directors since October 2018 and as its Chairman since October 2019. Luke previously served as the Executive Vice President and Chief Financial Officer of NPS Pharmaceuticals, Inc…

read more

JESSE SHEFFERMAN

Co-founder, Director, Chief Executive Officer

Jesse Shefferman is a co-founder of Protara and has led the Company since its inception through the addition of two late-stage assets, the establishment of multiple late-stage development programs and its listing on NASDAQ in early 2020…

read more
Jesse Shefferman
Michael Solomon, PhD

MICHAEL SOLOMON, PhD

Director

Dr. Michael Solomon has served on Protara’s board of directors since May 2018. He serves as Chief Executive Officer of Ribometrix, Inc., a company focused on targeting RNA with small molecules…

read more

BARRY FLANNELLY, PharmD, MBA

Director

Dr. Barry Flannelly has served on Protara’s board of directors since July 2020 and is currently the Executive Vice President and General Manager, North America at Incyte… 

read more
Barry Flannelly, PharmD, MBA
Roger Garceau, MD

ROGER GARCEAU, MD

Director

Dr. Roger Garceau has served on Protara’s board of directors since January 2019 and has more than 30 years of broad pharmaceutical industry experience in drugs, biologics and combination drug/device products for…

read more

Greg Sargen, MBA

Director

Greg Sargen has served on Protara’s board of directors since November 2019 and is a licensed CPA (inactive) with extensive experience working within the healthcare industry. Greg currently serves as Chief Financial Officer…

read more
Greg Sargen
Richard Levy, MD

Richard Levy, MD

Director

Dr. Richard Levy has served on Protara’s board of directors since December 2019 and has more than 25 years of experience in the pharmaceutical and biotechnology industries…

read more
Scroll to Top